5A60.0ICD-11 MMS 2026-01
Acromegaly or pituitary gigantism
Description
Acromegaly is an acquired disorder related to excessive production of growth hormone (GH) and characterised by progressive somatic disfigurement (mainly involving the face and extremities) and systemic manifestations. The main clinical features are broadened extremities (hands and feet), widened thickened and stubby fingers, and thickened soft tissue. The disease also has rheumatologic, cardiovascular, respiratory and metabolic consequences which determine its prognosis. In the majority of cases, acromegaly is related to a pituitary adenoma, either purely GH-secreting (60%) or mixed. Transsphenoidal surgery is often the first-line treatment. When surgery fails to correct GH/IGF-I hypersecretion, medical treatment with somatostatin analogs and/or radiotherapy can be used.
Index terms
- Acromegaly or pituitary gigantism
- Launois syndrome
- Marie disease
Show allHide
- Overproduction of growth hormone
- acromegalia
- acromegalic gigantism
- acromegaly
- anterior pituitary adenoma syndrome
- disorders with tall stature
- genetic giant
- giant
- giantism
- gigantism
- growth hormone hypersecretion
- growth hormone hypersecretion syndrome
- hypersomatotropic gigantism
- hypersomatotropism
- hypophyseal gigantism
- normal giant
- pituitary gigantism
- primordial giant
- Cardiomyopathy associated with acromegaly
- Somatotroph adenoma
- Arthropathy associated with acromegaly
- acromegalic arthritis
- acromegalic arthropathy
- acromegaly with arthropathy
Inclusions
- Overproduction of growth hormone
Excludes
5B12– Constitutional tall stature- http://id.who.int/icd/entity/1283179793 – increased secretion from endocrine pancreas of growth hormone-releasing hormone
Exclusions from above levels
Sibling codes
Foundation entity
Acromegaly or pituitary gigantism – http://id.who.int/icd/entity/825410563
Allowed postcoordination axes
Part of: 5A60: Hyperfunction of pituitary gland › 05: Endocrine, nutritional or metabolic diseases